CHRISTIAN GERWE: Open Payments
NPI 1245734375 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,183 in 73 payments from 11 companies in 2025. Trend: 2023 $616 · 2024 $1,364 · 2025 $1,183
Food & beverage: $983Consulting: $200
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 24 | $206 |
| Janssen Scientific Affairs, LLC | 1 | $200 |
| ABBVIE INC. | 21 | $187 |
| Indivior Inc. | 7 | $182 |
| Tris Pharma Inc | 8 | $137 |
| Braeburn Inc. | 5 | $104 |
| Alkermes, Inc. | 2 | $59 |
| Otsuka America Pharmaceutical, Inc. | 2 | $50 |
| Teva Pharmaceuticals USA, Inc. | 1 | $26 |
| Axsome Therapeutics, Inc. | 1 | $19 |
Products named: REXULTI, SPRAVATO, VRAYLAR, SUBLOCADE, Dyanavel XR, BRIXADI, LYBALVI, AUSTEDO XR.
Industry payments across AZ — which companies pay providers there.
